A panel of nanobodies are presented that can detect the spike proteins of five SARS-CoV-2 variants of concern and structural analyses show that one clone targets conserved epitopes on the receptor-binding domain and contacts the N-terminal domain.
- Ryota Maeda
- Junso Fujita
- Akifumi Takaori-Kondo
